#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Thomas R, Kalomenidis I, Jett J, Lee Y. Effusion from malignant causes. Textbook of pleural diseases. 2016;None.",Effusion from malignant causes,Textbook of pleural diseases,2016,,,,,,Thomas R; Kalomenidis I; Jett J; Lee Y
2,"Thomas R, Jenkins S, Eastwood PR, Lee Y, Singh B. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med. 2015;21.",Physiology of breathlessness associated with pleural effusions,Curr Opin Pulm Med,2015,21,,,,,Thomas R; Jenkins S; Eastwood PR; Lee Y; Singh B
3,"Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest. 2017;151.",US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample,Chest,2017,151,,,,,Taghizadeh N; Fortin M; Tremblay A
4,"Thomas R, Fysh E, Smith NA. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017;318.",Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial,JAMA,2017,318,,,,,Thomas R; Fysh E; Smith NA
5,"Davies H, Mishra E, Kahan B. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307.",Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial,JAMA,2012,307,,,,,Davies H; Mishra E; Kahan B
6,"Wahidi MM, Reddy C, Yarmus L. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195.",Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial,Am J Respir Crit Care Med,2017,195,,,,,Wahidi MM; Reddy C; Yarmus L
7,"Azzopardi M, Thomas R, Muruganandan S. Protocol of the Australasian Malignant Pleural Effusion2 (AMPLE2) trial: a multicentre randomised study of aggressive versus symptomguided drainage via indwelling pleural catheters. BMJ Open. 2016;6:11480.",Protocol of the Australasian Malignant Pleural Effusion2 (AMPLE2) trial: a multicentre randomised study of aggressive versus symptomguided drainage via indwelling pleural catheters,BMJ Open,2016,6,,11480,,,Azzopardi M; Thomas R; Muruganandan S
8,"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), shortform Mcgill pain questionnaire (SFMPQ), chronic pain grade scale (CPGS), short form36 bodily pain scale (SF36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res. 2011;63(suppl 11).","Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), shortform Mcgill pain questionnaire (SFMPQ), chronic pain grade scale (CPGS), short form36 bodily pain scale (SF36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP)",Arthritis Care Res,2011,63,suppl 11,,,,Hawker GA; Mian S; Kendzerska T; French M
9,"Mishra EK, Corcoran JP, Hallifax RJ, Stradling J, Maskell NA, Rahman NM. Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions. PLoS One. 2015;10:123798.",Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions,PLoS One,2015,10,,123798,,,Mishra EK; Corcoran JP; Hallifax RJ; Stradling J; Maskell NA; Rahman NM
10, EQ5D5L health questionnaire. EQ5D5L health questionnaire. 2009;None.,EQ5D5L health questionnaire,EQ5D5L health questionnaire,2009,,,,,,
11,Group E. EuroQol-a new facility for the measurement of healthrelated quality of life. Health Policy. 1990;16.,EuroQol-a new facility for the measurement of healthrelated quality of life,Health Policy,1990,16,,,,,Group E
12,"Herdman M, Gudex C, Lloyd A. Development and preliminary testing of the new fivelevel version of EQ5D (EQ5D5L). Qual Life Res. 2011;20.",Development and preliminary testing of the new fivelevel version of EQ5D (EQ5D5L),Qual Life Res,2011,20,,,,,Herdman M; Gudex C; Lloyd A
13,R. A language and environment for statistical computing. A language and environment for statistical computing. 2017;None.,A language and environment for statistical computing,A language and environment for statistical computing,2017,,,,,,R
14, EQ5D5L crosswalk index value calculator. EQ5D5L crosswalk index value calculator. 2018;None.,EQ5D5L crosswalk index value calculator,EQ5D5L crosswalk index value calculator,2018,,,,,,
15,"Van Hout B, Janssen MF, Feng YS. Interim scoring for the EQ5D5L: mapping the EQ5D5L to EQ5D3L value sets. Value Health. 2012;15.",Interim scoring for the EQ5D5L: mapping the EQ5D5L to EQ5D3L value sets,Value Health,2012,15,,,,,Van Hout B; Janssen MF; Feng YS
16,"Light RW, Rogers JT, Cheng DS, Rodriguez RM. Large pleural effusions occurring after coronary artery bypass grafting. Ann Intern Med. 1999;130.",Large pleural effusions occurring after coronary artery bypass grafting,Ann Intern Med,1999,130,,,,,Light RW; Rogers JT; Cheng DS; Rodriguez RM
17,"Bhatnagar R, Keenan EK, Morley AJ. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378.",Outpatient talc administration by indwelling pleural catheter for malignant effusion,N Engl J Med,2018,378,,,,,Bhatnagar R; Keenan EK; Morley AJ
18,"Clive AO, Kahan BC, Hooper CE. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69.",Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score,Thorax,2014,69,,,,,Clive AO; Kahan BC; Hooper CE
19,"Fysh E, Waterer GW, Kendall PA. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142.",Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion,Chest,2012,142,,,,,Fysh E; Waterer GW; Kendall PA
20,"Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions. Chest. 2018;153.",Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions,Chest,2018,153,,,,,Ost DE; Niu J; Zhao H; Grosu HB; Giordano SH
21,"Lui M, Thomas R, Lee Y. Complications of indwelling pleural catheter use and their management. BMJ Open Resp Res. 2016;3:e000123.",Complications of indwelling pleural catheter use and their management,BMJ Open Resp Res,2016,3,,e000123,,,Lui M; Thomas R; Lee Y
22,"Fysh E, Tremblay A, Fellerkopman D. Clinical outcomes of indwelling pleural catheterrelated pleural infections: an international multicenter study. Chest. 2013;144.",Clinical outcomes of indwelling pleural catheterrelated pleural infections: an international multicenter study,Chest,2013,144,,,,,Fysh E; Tremblay A; Fellerkopman D
23,"Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;21.",Estimation of minimally important differences in EQ5D utility and VAS scores in cancer,Health Qual Life Outcomes,2007,21,,,,,Pickard AS; Neary MP; Cella D
24,"Bhatnagar R, Zahanevans N, Kearney C. A novel drugeluting indwelling pleural catheter for the management of malignant effusions. Am J Respir Crit Care Med. 2018;197.",A novel drugeluting indwelling pleural catheter for the management of malignant effusions,Am J Respir Crit Care Med,2018,197,,,,,Bhatnagar R; Zahanevans N; Kearney C
25,"Sivakumar P, Douiri A, West A. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing outpatient talc slurry via indwelling pleural catheter for malignant pleural effusion vs usual inpatient management. BMJ Open. 2016;6:e012795.",OPTIMUM: a protocol for a multicentre randomised controlled trial comparing outpatient talc slurry via indwelling pleural catheter for malignant pleural effusion vs usual inpatient management,BMJ Open,2016,6,,e012795,,,Sivakumar P; Douiri A; West A
26,"Demmy TL, Gu L, Burkhalter JE. Optimal management of malignant pleural effusions. J Natl Compr Canc Netw. 2012;10.",Optimal management of malignant pleural effusions,J Natl Compr Canc Netw,2012,10,,,,,Demmy TL; Gu L; Burkhalter JE
27,"Putnam JB, Light RW, Rodriguez RM. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86.",A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions,Cancer,1999,86,,,,,Putnam JB; Light RW; Rodriguez RM
28,"Reddy C, Ernst A, Lamb C, Fellerkopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011;139.",Rapid pleurodesis for malignant pleural effusions: a pilot study,Chest,2011,139,,,,,Reddy C; Ernst A; Lamb C; Fellerkopman D
